Placeholder Banner

BIO Comments on ICH Q12 Draft Guideline

December 12, 2018

BIO submitted comments on the Food and Drug Administration (FDA) Draft Guideline, Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.

BIO appreciates FDA’s commitment to harmonization of regulatory concepts across regional Health Authorities through the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Harmonization of critical regulatory concepts is important to ensuring a consistent and predictable regulatory environment and gives sponsors confidence their drug development program will be generally accepted within different regions. BIO believes that the concepts in Q12 are important and warrant broad recognition across the globe.

BIO is encouraged by the work of the ICH Q12 working group but has concerns about implementation. BIO provides general and specific comments to strengthen and clarify the guideline. The comments cover topics including regional variability in implementation, Established Conditions (ECs), Post-Approval Change Management Protocol (PACMP), Product Lifecycle Management (PLCM), and more.

Download Full Comments Below
2018-12-15 BIO Comments On ICH Q12 FINAL
Read full comment letter below
Discover More
We write as a coalition of advocates for the startup ecosystem to voice our strong support for the IGNITE American Innovation Act, legislation to support startups through the economic crisis by allowing companies to monetize tax assets generated…
July 31, 2020 Re: Docket No. FDA–2020-N-0837: Raare Disease Clinical Trial Network; Request for Information. Dear Sir/Madam: The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the…
The following letter provides BIO’s feedback on a number of regulatory proposals by the Centers for Medicare & Medicaid Services that would ease barriers to use of value-based purchasing arrangements within Medicaid and commercial plans, broaden…